New partnership established to track drugs using blockchain
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
List view / Grid view
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
The global biobetters market is set to increase due to demand for higher efficacy and safer drugs.
A research team from Scripps Research Translational Institute has published revealing figures in relation to drug prices in the US.
New briefing documents provide policy recommendations to help the EU tackle high medicines prices brought about by market monopolies.
The EMA has accepted Prestige BioPharma’s marketing application for its trastuzumab biosimilar.
GlaxoSmithKline (GSK) has been given Chinese approval for its shingles vaccine.
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
Regulatory reforms and harmonisation reported as key drivers of industry in China.
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.
The single-use bioprocessing systems market in Asia Pacific has witnessed an impressive rise and is expected to continue growing.
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.